BMJ 2000;321:1362-1363 ( 2 December )

Editorials

Economic evaluation and clinical trials: size matters

The need for greater power in cost analyses poses an ethical dilemma

General practice pp 1383, 1389

The first 150 words of the full text of this article appear below.

Randomised trials of health care interventions are increasingly attempting to tackle issues of cost effectiveness as well as clinical effectiveness. A good example of this appears in the two papers describing the clinical1 and economic evaluation2 of psychological therapies in primary care in this issue of the BMJ (pp 1383,1389). The use of clinical trials as a vehicle for prospective cost effectiveness analysis presents challenges for successful evaluation, and the methods of conducting trial based economic evaluation are still in their infancy.

Several commentators have emphasised that health economists should be involved from the outset in the design of trials that seek to report on cost effectiveness,3 rather than being asked to add in the economic variables as an adjunct to the main trial (in a so called "piggyback" arrangement).4 The reason for this is because design considerations are different for clinical and economic analyses.

The tendency of resource use . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: Clinical effectiveness
Elaine Ward, Michael King, Margaret Lloyd, Peter Bower, Bonnie Sibbald, Sharon Farrelly, Mark Gabbay, Nicholas Tarrier, and Julia Addington-Hall
BMJ 2000 321: 1383-1388. [Abstract] [Full Text] [PDF]

Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: Cost effectiveness
Peter Bower, Sarah Byford, Bonnie Sibbald, Elaine Ward, Michael King, Margaret Lloyd, and Mark Gabbay
BMJ 2000 321: 1389-1392. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Hassiotis, A., Robotham, D., Canagasabey, A., Romeo, R., Langridge, D., Blizard, R., Murad, S., King, M. (2009). Randomized, Single-Blind, Controlled Trial of a Specialist Behavior Therapy Team for Challenging Behavior in Adults With Intellectual Disabilities. Am. J. Psychiatry 166: 1278-1285 [Abstract] [Full text]  
  • KNAPP, M., THORGRIMSEN, L., PATEL, A., SPECTOR, A., HALLAM, A., WOODS, B., ORRELL, M. (2006). Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis. Br. J. Psychiatry 188: 574-580 [Abstract] [Full text]  
  • Cullum, N., Spilsbury, K., Richardson, G. (2005). Nurse led care. BMJ 330: 682-683 [Full text]  
  • Feldman, H., Gauthier, S., Hecker, J., Vellas, B., Hux, M., Xu, Y., Schwam, E.M., Shah, S., Mastey, V. (2004). Economic evaluation of donepezil in moderate to severe Alzheimer disease. Neurology 63: 644-650 [Abstract] [Full text]  
  • Deshpande, S A, Northern, V (2003). The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch. Dis. Child. 88: 1065-1069 [Abstract] [Full text]  
  • Price, J. R (2003). Counselling may be more expensive than usual care for people with mental health problems, but may not be more effective for improving Beck depression score in the long term. Evid. Based Ment. Health 6: 127-127 [Full text]  
  • Bower, P., Byford, S., Barber, J., Beecham, J., Simpson, S., Friedli, K., Corney, R., King, M., Harvey, I. (2003). Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses. BMJ 326: 1247-1250 [Abstract] [Full text]  
  • Bozic, K. J., Rosenberg, A. G., Huckman, R. S., Herndon, J. H. (2003). Economic Evaluationin Orthopaedics. JBJS 85: 129-142 [Full text]  
  • Ashley, A., Lloyd, A., Lamb, S., Bartlett, H. (2001). Is health-related quality of life a suitable outcome measure for evaluating health promotion programmes?. Journal of Research in Nursing 6: 671-678 [Abstract]  
  • Brambleby, P. (2001). Should NICE's advice be handled centrally or locally?. BMJ 322: 613-613 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ